You are on page 1of 13

 + 

,+-.+) ,/+, 


)/. |.-- ) )
|/)/,, /) )0||
)|/ 0. ,1.
2)+),/)|/ 3
4

| 

   
   |  
| 
 | !
 " # $%&'$(
"|" &'
)
* 

!   ! 


     !! 

V  
 
The particular topic has been chosen because ±
ratio analysis enables the business owner and managers to identify
trends in a business by comparing the businesses own ratio for
several successive years.

By comparing a company¶s performance with average industry


performance, ratio analysis acts as an early warning indicator for
emerging unfavorable trends.

Further more, from the ratio analysis, potential investors & creditors
can have a better understanding of how the company is doing
financially & thus make more informative decisions.

Statement of the Problem


V  
V To identify any existing or emerging trends of Beximco Pharma by
comparing business¶s own ratios for successive 4 years ß  .

V To perform ratio analysis of BPL.

V To compare its performance with the average industry performance.

V To identify whether it is a sound decision for investors to invest in the


company & for creditors to lend the company.

V To suggest ways of improving the performance of the company.

Statement of the Problem


2 

Knalysis of the financial statements of the last 4 years


(2006-2009) was conducted and taken into consideration
in drawing conclusions.

    


The documented information from the
annual reports, personal interviews, performance reviews,
statistical data etc.

   
The main sources of secondary data
were books, newspaper articles, journal & the internet.

Statement of the Problem


V s one of the fastest growing sectors.
V From an import dependent country back in ¶70s, it is now almost
self sufficient industry meeting 97% of domestic demand
V uge export potentials
VTotal market size was BDT 5500 Crore in 2009 with 17% growth. &
216 registered pharma manufacturers.

2  , Bangladesh pharma industry is


V the 3rd highest contributor to the national exchequer
V the largest white-collar employment sector
V a Branded Generic market, with about 600 registered generics/
molecule & 7000 brands /items
V local manufacturers dominated, currently occupying 83% market share,
V Cs share are declining (currently 17% share).
V o C in the current top-10 list.

V  V
  

V a leading pharma company based in Dhaka

V a member of BEX CO Group, the largest


private sector industrial conglomerate in
Bangladesh.

   


V        
V   ß     

V           



V V
V 
   V 
 
 
VVV V 
    
 VV V 
 V  
V 

V  V   


 VV


V  
 

  

  
 
V V 

 ! "

V  

# V 


  
$ VV 
 
V   
%&'( 

& V  
% 
) 
 V  'V V   
 
$ & 
 V *
$ 
    


n Beximco Pharma, 3 types of methods or viewpoint are


used to Knalyze the Financial data for identifying the
comparative and relative significance ± which are :

1. Comparative analysis
2. Percentage (common size) analysis and
3. Ratio analysis
 
 

v     

 v    



 
 
 

                
v      ! " #        
v 
v" % "  
      
 
 $"  v" % "  !             
   &" "
 
 



 
 &" "  !   !   !  
!  
 ! 
 $ "            
) '(  # * * * *
 '( %
v   + ,(  #
*
*
*
*
 v    v  * * * *
&"
 
 

v     

 !- !   %  * * * *


" #                 
   . " % ,      
 '  '  #       

 
 # /  ' ( 0
 
     
1 # ,   
 
  

The 4 years financial data show a ë    of the


company. Beximco Pharma is a well-established and leading
Pharmaceuticals firm of the country.

Klthough BPL is run by an experienced management group, it could


not use it full potential due to some other internal & external crisis.

|  
V .' 2  %  (  "   #
3 . "   # 4% % ,"   , 2 5% %4 "
"     ,  % , " (    6 "  #  (
  5"  (  ,(       ,,,    (   ,%
3 &     ((  %%# " %7 "4#    ,%   #
  6    # ,, , 
3 .'    %  %   %  4   7    ( #
4% %   # (  % 8 4 %  %%  ( # 4% %   ((%   #
(
3 .' %   ,"   # (    5 91.&:   #  %
"   # ,  , # 5,
3  ,"    " 9v;1:8   ,      "  # ( ,( %
" ,,    ((    ##  5,
3   ,    ,"   # ,   91'0:  " ,   9!'0:
#( % & %   %4  " ,        %   , 2 #4
, %


 
Thank you all

You might also like